Abstract: The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.

Abstract: The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.

Abstract: The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.

Abstract: The invention relates to peroral solid analgesic formulations containing opioids and/or morphine analogues in an effect-retarding matrix.

Abstract: The present invention relates to orally administerable medicinal plant dry extracts, wherein the non-volatile phase of the extract is bound in a microdisperse form and/or in the form of a semisolid or solid solution to a first carrier which is soluble in or miscible with alcohol, soluble in or miscible with water and solid at room temperature, optionally in addition to other auxiliaries and/or additives. Optionally, a second carrier is selected from carriers which are insoluble in alcohol, insoluble in water or swellable in water and solid at room temperature, or alkaline earth metal and/or alkali metal carbonates including hydrogencarbonates.